Disitamab vedotin is under clinical development by Pfizer and currently in Phase II for Metastatic Transitional (Urothelial) Tract Cancer. According to GlobalData ... in addition to indication ...
The National Bureau of Statistics said the total number of people in China dropped by 1.39 million to 1.408 billion in 2024, compared to 1.409 billion in 2023. Friday's (Jan 17) data reinforces ...
Copyright 2025 The Associated Press. All Rights Reserved. China’s population fell last year for the third straight year, its government said Friday, pointing to ...